Clinical Trial

Virus as Treatment of C. Difficile Infection (VISION)

Study acronym: VISION
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 3, 2024 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Fecal Virome Transplantation (FVT) has in small studies shown benefit in the treatment of recurrent C. difficile infection. In the VISION study we will treat patients with recurrent C. difficile infection with FVT capsules and compare the treatment with Fecal Microbiota Transplantation (FMT) capsules. Both will be following af standard treatment of antibiotics (Vancomycin)
Trial Details
NCT Number NCT06398379
Lead Sponsor Copenhagen University Hospital, Hvidovre
Collaborators: University of Copenhagen
Conditions Clostridium Difficile Infections
Enrollment 40 participants
Start Date 2024-05-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-05-03